RHEB gene therapy maintains the chondrogenic characteristics and protects cartilage tissue from degenerative damage during experimental murine osteoarthritis-Reference-Cited by-同舟云学术

RHEB gene therapy maintains the chondrogenic characteristics and protects cartilage tissue from degenerative damage during experimental murine osteoarthritis

Published:2019-10 Issue:10 Volume:27 Page:1508-1517
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Ashraf S.,Kim B.J.,Park S.,Park H.,Lee S.-H.

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Ministry of Health & Welfare

Research of Korea Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference37 articles.

1. Gene therapy for human osteoarthritis: principles and clinical translation;Madry;Expert Opin Biol Ther,2016

2. RHEB: a potential regulator of chondrocyte phenotype for cartilage tissue regeneration;Ashraf;J Tissue Eng Regenerat Med,2017

3. Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration;Akkiraju;J Dev Biol,2015

4. Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration;Ashraf;Osteoarthritis Cartilage,2016

5. Articular cartilage: injury pathways and treatment options;Simon;Sports Med Arthrosc Rev,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis;Cellular & Molecular Biology Letters;2024-05-02

2. Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway;International Immunopharmacology;2024-05

3. Current therapies for osteoarthritis and prospects of CRISPR-based genome, epigenome, and RNA editing in osteoarthritis treatment;Journal of Genetics and Genomics;2023-07

4. Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review;Frontiers in Medicine;2023-04-03

5. Osteoarthritis gene therapy in 2022;Current Opinion in Rheumatology;2022-11-09